清空九洲药业持股，浙江富豪花轩德“隐退” 此前现身北大医药控股股东重组事件

Core Viewpoint - The actual controller of Jiuzhou Pharmaceutical, Hua Xuande, has transferred his shares to his daughters, resulting in a change in the company's control structure, primarily due to Hua's advanced age [2][3][4]. Share Transfer Details - Hua Xuande transferred 42.5% of his shares in Zhejiang Zhongbei Jiuzhou Group and 10% in Taizhou Gede Industrial to his daughters, Hua Lirong and Hua Xiaohui [3][4]. - After the transfer, Hua Lirong holds 22.17% of Jiuzhou Pharmaceutical directly and indirectly, while Hua Xiaohui holds 13.36% indirectly [2][3]. Financial Aspects - The total value of the shares transferred from Zhongbei Group was 61.115 million yuan, and the shares from Taizhou Gede were valued at 700,000 yuan [4]. Background Information - Hua Xuande, born in 1943, is 82 years old and has gradually stepped back from management roles in Jiuzhou Pharmaceutical over recent years [5][9]. - The company was founded focusing on the research, production, and sales of chemical raw materials and pharmaceutical intermediates, later transitioning to contract custom development and production [9]. Control Structure Post-Transfer - Following the transfer, the actual controllers of Jiuzhou Pharmaceutical are now Hua Lirong and Hua Xiaohui, with Zhongbei Group remaining the controlling shareholder [4][8].